Core Insights - The medical beauty sector experienced a 1.15% increase on November 13, with *ST Meigu leading the gains [1] - The Shanghai Composite Index closed at 4029.5, up 0.73%, while the Shenzhen Component Index closed at 13476.52, up 1.78% [1] Medical Beauty Sector Performance - *ST Meigu (000615) closed at 4.77, with a rise of 5.07% and a trading volume of 105,700 shares, amounting to a transaction value of 50.0584 million yuan [1] - Jinbo Biological (920982) closed at 238.31, up 2.24%, with a trading volume of 11,200 shares and a transaction value of 268 million yuan [1] - Aimeike (300896) closed at 159.60, up 1.22%, with a trading volume of 33,700 shares and a transaction value of 534 million yuan [1] - Huaxi Biological (688363) closed at 51.77, up 0.52%, with a trading volume of 19,300 shares and a transaction value of 9.9559 million yuan [1] Fund Flow Analysis - The medical beauty sector saw a net outflow of 48.455 million yuan from institutional investors, while retail investors contributed a net inflow of 20.9995 million yuan [1] - Specific fund flows for key companies include: - *ST Meigu: Institutional net outflow of 384,800 yuan, retail net inflow of 113,790 yuan [2] - Huaxi Biological: Institutional net outflow of 15.0817 million yuan, retail net inflow of 13.8661 million yuan [2] - Aimeike: Institutional net outflow of 32.9885 million yuan, retail net inflow of 599,550 yuan [2]